期刊文献+

胰岛素抵抗与子宫内膜癌关系的研究进展 被引量:5

原文传递
导出
摘要 子宫内膜癌是妇科的第二大恶性肿瘤,发病率逐年升高并伴有发病年轻化的趋势,严重威胁妇女健康.“无拮抗的雌激素作用”导致子宫内膜癌变的发生、发展是目前流行的释因假说.然而,随着对其病因研究的深入,更多的机制逐渐被证实.近年来,越来越多的研究证据表明,胰岛素抵抗是子宫内膜癌发病的危险因素.本文将从循证医学证据、发病机制、临床早期干预的策略3个方面综述胰岛素抵抗与子宫内膜癌的关系.
作者 郭静 杨冬梓
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2015年第1期73-75,共3页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献24

  • 1Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome[J]. Hum Reprod, 2012,27(5):1327-1331.
  • 2高劲松,沈铿,郎景和,黄惠芳,潘凌亚,吴鸣,金滢,陈琼华.45岁以下子宫内膜癌患者的临床分析[J].中华妇产科杂志,2004,39(3):159-161. 被引量:71
  • 3Ni RM, Mo Y, Chen X, et al. Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome[J]. Eur J Endocrinol, 2009,161 ( 3 ) :411-418.
  • 4Esposito K, Chiodini P, Capuano A, et al. Metabolic syndrome and endometrial cancer: a meta-analysis[J]. Endocrine, 2014,45 ( 1 ):28-36.
  • 5徐望红,戴奇,阮志贤,程家蓉,金凡,舒晓鸥.肥胖与子宫内膜癌关系的病例对照研究[J].中华流行病学杂志,2002,23(5):347-351. 被引量:24
  • 6Friberg E, Orsini N, Mantzoros CS, et al. Diabetes meUitus andrisk of endometrial cancer: a meta-analysis[J]. Diabetologia, 2007,50(7):1365-1374.
  • 7Zhang ZH, Su PY, Hao JH, et al. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies[J]. Int J Gynecol Cancer, 2013,23(2):294-303.
  • 8Gunter M J, Hoover DR, Yu H, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer[J]. Cancer Epidemiol Biomarkers Prey, 2008.17 (4):921-929.
  • 9张果,李小平,王建六,魏丽惠.子宫内膜癌细胞和组织中胰岛素受体亚型的表达及作用的初步探讨[J].中华妇产科杂志,2012,47(11):839-845. 被引量:11
  • 10华绍芳,薛凤霞,张丽志,王颖梅,赵敬.子宫内膜癌组织中胰岛素受体底物1的表达与活化及其临床意义[J].中华妇产科杂志,2008,43(6):437-441. 被引量:6

二级参考文献31

  • 1刘霞,张为远,代荫梅.子宫内膜癌相关危险因素研究进展[J].中国全科医学,2009,12(12):1128-1131. 被引量:23
  • 2侯琦,王庆生,王继芳,白秀云,董淑芬,陈.天津市子宫内膜癌发病危险因素的调查分析[J].中华妇产科杂志,1994,29(1):30-32. 被引量:6
  • 3张春瑶,王天根.北京市150例子宫内膜癌的病例对照研究[J].中华流行病学杂志,1989,10(4):235-237. 被引量:2
  • 4Petridou E, Koukoulomatis P, Alexe DM, et al. Endometrial cancer and the IGF system: a ease-control study in Greece. Oneology, 2003,64 :341-345.
  • 5Han CH, Cho JY, Moon JT, et al. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer. Oncol Rep, 2006,16 : 1205-1210.
  • 6Lee AV, Jackson JG, Gooeh JL, et al. Enhancement of insulinlike growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endoerinol, 1999, 13 : 787-796.
  • 7Dunaif A, Wu X, Lee A, et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome. Am J Physiol Endocrinol Metab,2001, 281:392-399.
  • 8Dalmizrak O, Wu A, Chen J, et al. Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer celia Cancer Res, 2007,67:2124-2130.
  • 9Byron SA, Horwitz KB, Richer JK, et al. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. Br J Cancer, 2006,95 : 1220-1228.
  • 10Dearth RK, Cui X, Kim HJ, et aL Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 ( IRS-1 ) or IRS-2. Mol Cell Biol, 2006,26:9302-9314.

共引文献114

同被引文献22

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部